Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study

Author:

Arnold Suzanne V.12ORCID,Khunti Kamlesh3,Tang Fengming1,Chen Hungta4,Nicolucci Antonio5,Gomes Marilia B.6ORCID,Ji Linong7ORCID,Shestakova Marina V.8,Watada Hirotaka9,Cooper Andrew10,Fenici Peter10,Hammar Niklas1112,Medina Jesús13,Kosiborod Mikhail1214,

Affiliation:

1. Saint Luke’s Mid America Heart Institute Kansas City Missouri USA

2. University of Missouri Kansas City Missouri USA

3. University of Leicester Leicester UK

4. AstraZeneca Gaithersburg Maryland USA

5. Center for Outcomes Research and Clinical Epidemiology Pescara Italy

6. Rio de Janeiro State University Rio de Janeiro Brazil

7. Peking University People’s Hospital Beijing China

8. Endocrinology Research Centre Diabetes Institute Moscow Russian Federation

9. Graduate School of Medicine Juntendo University Tokyo Japan

10. AstraZeneca Cambridge UK

11. AstraZeneca Gothenburg Mölndal Sweden

12. Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

13. AstraZeneca Madrid Spain

14. The George Institute for Global Health and University of New South Wales Sydney Australia

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3